These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3094481)

  • 1. Quantitation of corneal inflammation by chemiluminescense.
    Chusid MJ; Shea ML
    Arch Ophthalmol; 1986 Oct; 104(10):1540-4. PubMed ID: 3094481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte kinetics in experimentally induced keratitis.
    Chusid MJ; Davis SD
    Arch Ophthalmol; 1985 Feb; 103(2):270-4. PubMed ID: 3977698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the polymorphonuclear leukocyte in the induction of corneal edema.
    Chusid MJ; Nelson DB; Meyer LA
    Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1466-9. PubMed ID: 3759365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of topical honey in the treatment of corneal abrasions and endotoxin-induced keratitis in an animal model.
    Uwaydat S; Jha P; Tytarenko R; Brown H; Wiggins M; Bora PS; Bora NS
    Curr Eye Res; 2011 Sep; 36(9):787-96. PubMed ID: 21812661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the cornea to cytokine levels in the whole eye induced during the early phase of Pseudomonas aeruginosa challenge.
    Cole N; Hume E; Khan S; Madigan M; Husband AJ; Garthwaite L; Willcox M
    Immunol Cell Biol; 2005 Jun; 83(3):301-6. PubMed ID: 15877609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia increases corneal cell expression of CFTR leading to increased Pseudomonas aeruginosa binding, internalization, and initiation of inflammation.
    Zaidi T; Mowrey-McKee M; Pier GB
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4066-74. PubMed ID: 15505057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection.
    Kernacki KA; Barrett RP; Hobden JA; Hazlett LD
    J Immunol; 2000 Jan; 164(2):1037-45. PubMed ID: 10623854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nona-D-arginine amide suppresses corneal cytokines in Pseudomonas aeruginosa keratitis.
    Karicherla P; Aras S; Aiyar A; Hobden JA
    Cornea; 2010 Nov; 29(11):1308-14. PubMed ID: 20802321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
    Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist.
    Esquenazi S; He J; Bazan HE; Bazan NG
    J Cataract Refract Surg; 2004 Apr; 30(4):884-91. PubMed ID: 15093656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense.
    Chusid MJ; Davis SD
    Infect Immun; 1979 Jun; 24(3):948-52. PubMed ID: 112062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased susceptibility to infection in experimental xerophthalmia.
    DeCarlo JD; Van Horn DL; Hyndiuk RA; Davis SD
    Arch Ophthalmol; 1981 Sep; 99(9):1614-7. PubMed ID: 6793031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model.
    Cole N; Willcox MD; Fleiszig SM; Stapleton F; Bao B; Tout S; Husband A
    Curr Eye Res; 1998 Jul; 17(7):730-5. PubMed ID: 9678419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryotherapy of Pseudomonas keratitis and scleritis.
    Eiferman RA
    Arch Ophthalmol; 1979 Sep; 97(9):1637-9. PubMed ID: 383051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
    Huang X; Barrett RP; McClellan SA; Hazlett LD
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune system in experimental Pseudomonas keratitis. Model and early effects.
    Twining SS; Lohr KM; Moulder JE
    Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):507-15. PubMed ID: 3082789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.
    Hobden JA; Hill JM; Engel LS; O'Callaghan RJ
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1856-9. PubMed ID: 8239596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Pseudomonas aeruginosa keratitis from extended wear of soft contact lenses.
    Koch JM; Refojo MF; Hanninen LA; Leong FL; Kenyon KR
    Arch Ophthalmol; 1990 Oct; 108(10):1453-9. PubMed ID: 2121123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.